Public Health On Call - 607: How The FDA Can Help More People Stop Smoking

607: How The FDA Can Help More People Stop Smoking

05/01/23 • 15 min

1 Listener

In a recent commentary in the New England Journal of Medicine, Johns Hopkins tobacco policy expert Joanna Cohen and colleagues call for the FDA to take steps to bring more smoking cessation therapies to the market. Cohen, director of the Institute for Global Tobacco Control, talks with Dr. Josh Sharfstein about why new therapies are needed and where to find evidence to support their use. Read the full commentary here: https://www.nejm.org/doi/full/10.1056/NEJMp2301700. If you or someone you know needs help with quitting tobacco products, call 1-800-QUITNOW.

Previous Episode

606 - What Happens Next with Mifepristone?

To understand what happens now that SCOTUS has stayed Judge Matthew Kacsmaryk’s ruling on mifepristone, we first have to understand how the case got to the highest court in the land in the first place. Public health lawyer Joanne Rosen returns to the podcast to talk with Dr. Josh Sharfstein about the unprecedented series of filings and rulings around mifepristone from Amarillo, Texas to Washington D.C., and what could happen next as litigation continues to play out.

Next Episode

608 - What May Happen When the COVID-19 Public Health Emergency Ends on May 11

Jennifer Kates, senior vice president and director of global health and HIV policy at KFF, returns to the podcast to talk with Lindsay Smith Rogers about the looming expiration of the COVID-19 public health emergency and what that means for things like access to tests, treatments, vaccines, and eligibility for Medicaid. They also discuss the differences between this and the national health emergency that Biden ended in April, and why both are significant symbolic gestures at a time when a new variant is emerging.